Gene: ZSCAN21
Official Full Name: zinc finger and SCAN domain containing 21provided by HGNC
Gene Summary: Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Involved in positive regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO34703 | ZSCAN21 Knockout cell line (HeLa) | Human | ZSCAN21 | 1:3~1:6 | Negative | Online Inquiry |
KO34704 | ZSCAN21 Knockout cell line (HCT 116) | Human | ZSCAN21 | 1:2~1:4 | Negative | Online Inquiry |
KO34705 | ZSCAN21 Knockout cell line (HEK293) | Human | ZSCAN21 | 1:3~1:6 | Negative | Online Inquiry |
KO34706 | ZSCAN21 Knockout cell line (A549) | Human | ZSCAN21 | 1:3~1:4 | Negative | Online Inquiry |
ZSCAN21 Gene Knockout Cell Lines represent a groundbreaking tool in the realm of genetic research, specifically designed to facilitate the study of ZSCAN21, a transcription factor implicated in various biological processes and disorders. These cell lines have been meticulously engineered through CRISPR/Cas9 technology to introduce targeted deletions in the ZSCAN21 gene, allowing for the comprehensive examination of its functional role in cellular signaling, gene regulation, and disease pathology.
The key functionality of ZSCAN21 Gene Knockout Cell Lines lies in their ability to enable researchers to observe the phenotypic and molecular consequences of ZSCAN21 loss-of-function. By employing these cell lines, scientists can unveil intricate mechanisms involving ZSCAN21 in processes such as immune response modulation, cellular differentiation, and development. This makes them invaluable for dissecting the contributions of ZSCAN21 in various pathologies, including autoimmune diseases and cancer.
In the scientific landscape, the importance of ZSCAN21 gene knockout models is amplified due to their application in both basic research and translational medicine. These cell lines provide a critical platform for testing novel therapeutic strategies aimed at manipulating ZSCAN21 pathways, thereby bridging the gap between laboratory research and clinical applications.
The unique selling points of ZSCAN21 Gene Knockout Cell Lines compared to alternative models lie in their specificity, consistency, and ease of use. Unlike conventional knockout models that may carry off-target effects or lack precise gene editing, these cell lines boast high specificity, ensuring reliable experimental outcomes. Additionally, the time-efficient generation and validation of these cell lines significantly reduce research timelines, providing researchers with a rapid avenue for exploration.
For researchers and clinicians seeking to understand the molecular underpinnings of disease and develop innovative therapeutic strategies, ZSCAN21 Gene Knockout Cell Lines offer a robust and reliable platform. By equipping the scientific community with high-quality tools, our company is committed to advancing research and enhancing the understanding of genetic factors influencing human health and disease. Our expertise in cellular models and genetic engineering sets us apart, ensuring that users can trust the quality and performance of our products.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.